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When humans get older, organs fail, disease ensues, and the inevitability of death follows. 
Aging increases the likelihood of the onset of age-related diseases such as Alzheimer’s, heart 
disease, and cancer. Aging is commonly not seen as a disease, but as an untreatable, natural 
process. However, aging has recognizable causes on the molecular level, and many argue for 
its classification as a disease. Utilizing these known molecular pathways of lifespan extension, 
we have found drugs that significantly increase the lifespan of single-celled yeast and tiny 
roundworms. These drugs act in the way of increasing the expression of a protein whose 
human version is ATF4. If this gene is removed, these drugs no longer extend lifespan. These 
drugs increase autophagy levels in the cell. Autophagy is a process your cells undergo to 
recycle damaged proteins to replace them with better functioning proteins. If we block 
autophagy, similarly, these drugs do not increase lifespan. We believe that these drugs act 
through the ATF4 gene to increase autophagy. Having had confirmed this in worms and 
yeast, testing the drugs’ activity in mammalian cells is the next step. Understanding how 
these drugs act in mammalian cells will give us insight into if and how they extend healthspan 
in mammals, which would provide further information into how the aging pathway works in 
humans. Delaying aging could not just extend the human lifespan, but delay the onset of 
many mortifying age-associated diseases and improve the quality of life for everyone. 
 
